EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming (Q47600932)

4 February 2018

http://europepmc.org/abstract/MED/28978636

title

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming (English)

1 reference

4 February 2018

http://europepmc.org/abstract/MED/28978636

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Milan Radovich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Bradley Hancock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Giulio F Draetta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Justin Budka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Nur P Damayanti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Justine Arrington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mary Ferris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Chuan-Chih Hsu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sreenivasulu Chintala

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ashley Orillion

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kiersten Marie Miles

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Li Shen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

May Elbanna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Eric Ciamporcero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sreevani Arisa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Piergiorgio Pettazzoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mukund Seshadri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Janaiah Kota

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Michael Buck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Heike Keilhack

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Brian P McCarthy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Scott A Persohn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Paul R Territo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yong Zang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

W Andy Tao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Peter Hollenhorst

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Roberto Pili

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

4 October 2017

1 reference

4 February 2018

http://europepmc.org/abstract/MED/28978636

published in

Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

6651-6666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

1 June 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC5712262/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Targeting renal cell carcinoma with a HIF-2 antagonist.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphoma.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Animal models of colorectal cancer with liver metastasis

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

29 September 2018

Targeting EZH2 in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Poised epigenetic states and acquired drug resistance in cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Sunitinib re-challenge in advanced renal-cell carcinoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Adaptive reprogramming of the breast cancer kinome

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Prognostic value of EZH2 expression and activity in renal cell carcinoma: a prospective study

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

New mechanisms in memory storage: piRNAs and epigenetics

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Fluorescence lifetime imaging of biosensor peptide phosphorylation in single live cells.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Targeting the protein kinases for anti-cancer therapy

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Patient-derived tumour xenografts as models for oncology drug development

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Vascular disruption in combination with mTOR inhibition in renal cell carcinoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Targeting cancer with small-molecular-weight kinase inhibitors

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Regulation of tumor angiogenesis by EZH2.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Cell signaling by receptor tyrosine kinases

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Signal transduction by focal adhesion kinase in cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

The polycomb group protein EZH2 is involved in progression of prostate cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5712262

Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets

29 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28978636

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-17-0899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28978636%20AND%20SRC:MED&resulttype=core&format=json